Nandrolone


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult: IM Anabolic after debilitating illness; Metastatic breast carcinoma; Postmenopausal osteoporosis As nandrolone decanoate: 25-100 mg 3-4 weekly. Anaemia of chronic renal failure As nandrolone decanoate: Female: 50-100 mg per week. Male: 100-200 mg per week. Aplastic anaemia As nandrolone decanoate: 50-150 mg per week.
Contraindications
Prostatic or breast carcinoma (male); nephrosis, porphyria; infants, pregnancy and lactation.
Special Precautions
Monitor diabetic patients carefully. Conditions influenced by oedema (e.g. CV disease, migraine, seizure disorder, renal impairment). Hepatic impairment. Elderly. Discontinue if signs of virilisation in women occur. Monitor skeletal maturation in children.
Adverse Reactions
Male: Postpubertal: Acne, gynaecomastia, bladder irritability, priapism, insomnia, chills, decreased libido, hepatic dysfunction, nausea, diarrhoea, prostatic hyperplasia. Prepubertal: Acne, virilism, chills, insomnia, hyperpigmentation, diarrhoea, nausea. Female: Virilism, hypercalcaemia, nausea, diarrhoea, chills, insomnia, iron deficiency anaemia, hepatic dysfunction.
Drug Interactions
May increase effects of oral anticoagulants, insulin, oral antidiabetic agents, adrenal steroid, adrenocorticotropic hormone (ACTH).
CIMS Class
ATC Classification
A14AB01 - nandrolone ; Belongs to the class of estren derivative anabolic steroids used as systemic anabolic agents.
S01XA11 - nandrolone ; Belongs to the class of other ophthalmologicals.
Disclaimer: This information is independently developed by CIMS based on nandrolone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
MORE
LESS
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in